Press release

C-RAD’s SGRT Solutions Chosen for Training Curriculum for Future Radiation Therapists

Australia’s Global Centre for Research and Training in Radiation Oncology propels SGRT forward as standard of care by selecting C-RAD as an industry training partner

The Global Centre for Research and Training in Radiation Oncology (GC-RTRO), supported by the University of Newcastle, is the first of its kind to bring radiation oncology research and training activities to the forefront of the global drive to advance cancer care by training the next generation of radiation therapists. GC-RTRO invested in C-RAD’s Catalyst system to fully train students with hands-on experience on the latest surface guided radiation therapy (SGRT) techniques.

“Our partners all share our vision; to elevate the standard of cancer care globally. Each partner is invested in supporting student education and advocates for radiation oncology,” states Associate Professor Yolanda Surjan, Director of Global Centre for Research and Training in Radiation Oncology. “Being at the forefront of clinical practice is what sets our students apart, allowing students to enter the workforce feeling confident and ready. And SGRT is a critical technology in the fast-progressing oncology space.”

C-RAD’s system is integrated on an Elekta Versa HD™ linear accelerator in a purpose-built bunder designed to simulate a clinical setting.

“Surface tracking being integrated in the curriculum for the training program of future therapists, is yet another important milestone on the journey to make the technology standard of care in advanced radiation therapy,” says Tim Thurn, CEO and President of C-RAD AB. “C-RAD is proud to be part of this educational program supporting clinicians and students to deliver the highest level of care to their patients.”

“We are excited to have the first academic training program, that teaches young students the use of surface tracking, in Australia. This teaching facility is the first in the world to be equipped with advanced SGRT technology,’’ states James Nguyen, C-RAD’s Director of Sales Asia Pacific. “This cooperation is a huge opportunity; we envision to develop programs in the format of a clinical training school for domestic and international users of the C-RAD technology.”

For more information about GC-RTRO, visit https://www.newcastle.edu.au/research/centre/gc-rtro.

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com